Kamu erişimi zorunlu olan makaleler - Michael A. Gorin, M.D.Daha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 14
Imaging of prostate-specific membrane antigen with small-molecule PET radiotracers: from the bench to advanced clinical applications
SP Rowe, MA Gorin, MG Pomper
Annual review of medicine 70 (1), 461-477, 2019
Zorunlu olanlar: US National Institutes of Health
Comorbidities and causes of death in the management of localized T 1a kidney cancer
HD Patel, M Kates, PM Pierorazio, MA Gorin, G Jayram, MW Ball, ...
International Journal of Urology 21 (11), 1086-1092, 2014
Zorunlu olanlar: US National Institutes of Health
Recent advances and current role of transperineal prostate biopsy
Y Bhanji, MJ Allaway, MA Gorin
Urologic Clinics of North America 48 (1), 25-33, 2021
Zorunlu olanlar: US National Institutes of Health
Pharmacotherapy of head and neck squamous cell carcinoma
Q Pan, MA Gorin, TN Teknos
Expert opinion on pharmacotherapy 10 (14), 2291-2302, 2009
Zorunlu olanlar: US National Institutes of Health
Defining the role of intraoperative transesophageal echocardiography during radical nephrectomy with inferior vena cava tumor thrombectomy for renal cell carcinoma
MP Kostibas, V Arora, MA Gorin, MW Ball, PM Pierorazio, ME Allaf, ...
Urology 107, 161-165, 2017
Zorunlu olanlar: US National Institutes of Health
Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI
MJ Connor, MA Gorin, HU Ahmed, R Nigam
Prostate Cancer and Prostatic Diseases 23 (2), 232-243, 2020
Zorunlu olanlar: Cancer Research UK, UK Medical Research Council, National Institute for …
Imaging of prostate-specific membrane antigen using [18F] DCFPyL
SP Rowe, MA Gorin, MG Pomper
PET clinics 12 (3), 289-296, 2017
Zorunlu olanlar: US National Institutes of Health
Development of a nationally representative coordinated registry network for prostate ablation technologies
R Golan, A Bernstein, A Sedrakyan, TJ Daskivich, DT Du, B Ehdaie, ...
The Journal of urology 199 (6), 1488-1493, 2018
Zorunlu olanlar: US National Institutes of Health
Clinical experience with 18F-labeled small molecule inhibitors of prostate-specific membrane antigen
SP Rowe, MA Gorin, RAS Fragomeni, A Drzezga, MG Pomper
PET clinics 12 (2), 235-241, 2017
Zorunlu olanlar: US National Institutes of Health
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [111In]In‐XYIMSR …
RA De Silva, MA Gorin, RC Mease, I Minn, A Lisok, D Plyku, ...
Journal of Labelled Compounds and Radiopharmaceuticals 64 (6), 243-250, 2021
Zorunlu olanlar: US National Institutes of Health
Validation of a zero-shot learning natural language processing tool to facilitate data abstraction for urologic research
B Kaufmann, D Busby, CK Das, N Tillu, M Menon, AK Tewari, MA Gorin
European Urology Focus 10 (2), 279-287, 2024
Zorunlu olanlar: Swiss Cancer League
Biopsy and erectile functional outcomes of partial prostate ablation: a systematic review and meta-analysis of prospective studies
D Busby, JM Rich, R Grauer, B Kaufmann, K Pandav, A Sood, AK Tewari, ...
Urology 182, 14-26, 2023
Zorunlu olanlar: US Department of Defense, US National Institutes of Health
MP09-01 THE ROLE OF PROPHYLACTIC ANTIBIOTICS IN TRANSPERINEAL PROSTATE BIOPSY: A SYSTEMATIC REVIEW AND METANALYSIS
S Basourakos, M Alshak, P Lewicki, E Cheng, M Tzeng, A DeRosa, ...
Journal of Urology 207 (Supplement 5), e135, 2022
Zorunlu olanlar: Patient-Centered Outcomes Research Institute
VARIABILITY IN GROWTH KINETICS OF SMALL RENAL MASSES ON ACTIVE SURVEILLANCE: RESULTS FROM THE DISSRM REGISTRY: PD59-02
A Uzosike, M Johnson, H Patel, M Riffon, M Gorin, C Pavlovich, P Chang, ...
Journal of Urology 197 (4), e1133, 2017
Zorunlu olanlar: US National Institutes of Health
Bir yerde sunuluyor: 116
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
Zorunlu olanlar: US National Institutes of Health
Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters
KJ Cheung, V Padmanaban, V Silvestri, K Schipper, JD Cohen, ...
Proceedings of the National Academy of Sciences 113 (7), E854-E863, 2016
Zorunlu olanlar: US National Institutes of Health
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer …
KJ Pienta, MA Gorin, SP Rowe, PR Carroll, F Pouliot, S Probst, ...
The Journal of urology 206 (1), 52-61, 2021
Zorunlu olanlar: US National Institutes of Health
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
MJ Morris, SP Rowe, MA Gorin, L Saperstein, F Pouliot, D Josephson, ...
Clinical Cancer Research 27 (13), 3674-3682, 2021
Zorunlu olanlar: US National Institutes of Health
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
JJ Tosoian, MA Gorin, AE Ross, KJ Pienta, PT Tran, EM Schaeffer
Nature Reviews Urology 14 (1), 15-25, 2017
Zorunlu olanlar: US Department of Defense, US National Institutes of Health
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ...
European journal of nuclear medicine and molecular imaging 44, 2117-2136, 2017
Zorunlu olanlar: US National Institutes of Health
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir